Research Article

The Therapeutic Effect of p-Coumaric Acid on Lung Toxicity Induced by Methotrexate in Rats

Volume: 3 Number: 2 June 30, 2024
TR EN

The Therapeutic Effect of p-Coumaric Acid on Lung Toxicity Induced by Methotrexate in Rats

Abstract

The use of methotrexate (MTX), a chemotherapy agent, is limited by a number of side effects, including pulmonary toxicity. Oxidative stress (OS) and inflammation are possible mechanisms of MTX-associated pulmonary toxicity. p-Coumaric acid (PCA) is a phenolic acid that has been demonstrated to exert a number of beneficial effects on human health, particularly in relation to antioxidant and anti-inflammatory activity. The potential effects of PCA in reducing MTX-induced pulmonary toxicity were investigated in the current study. After MTX (20 mg/kg) was administered to the rats on day 1, two different doses of PCA (2 and 4 mg/kg) were administered intraperitoneally for 3 days and the levels of OS, inflammation and apoptosis were assessed in the lung tissues collected on day 5. PCA applications largely eliminated MTX-induced OS, inflammation and apoptosis in lung tissue via enhancing the capacity of endogenous antioxidant system. The therapeutic effect of PCA against MTX-induced pulmonary toxicity should be re-evaluated in more systematic studies.

Keywords

Apoptosis , Inflammation , Methotrexate , Oxidative stress , p-Coumaric acid , Pulmonary toxicity

References

  1. Patel NN, Ghodasara DJ, Pandey S, et al. Subacute toxicopathological studies of methotrexate in Wistar rats. Veterinary World. 2014;7(7):489-495.
  2. Hamed KM, Dighriri IM, Baomar AF, et al. Overview of methotrexate toxicity: A Comprehensive literature review. Cureus. 2022;14(9):e29518. doi:10.7759/cureus.29518
  3. Gaies E, Jebabli N, Trabelsi S, et al. Methotrexate side effects: Review article. J Drug Metab Toxicol. 2012;3:4. doi:10.4172/2157-7609.1000125
  4. Ohbayashi M, Suzuki M, Yashiro Y, et al. Induction of pulmonary fibrosis by methotrexate treatment in mice lung in vivo and in vitro. J Toxicol Sci. 2010;35(5):653-661. doi:10.2131/jts.35.653
  5. Zaki SM, Hussein GHA, Khalil HMA, Abd Algaleel WA. Febuxostat ameliorates methotrexate-induced lung damage. Folia Morphol (Warsz). 2021;80(2):392-402. doi:10.5603/FM.a2020.0075
  6. Althagafy HS, Sharawi ZW, Batawi AH, et al. Buspirone attenuated methotrexate-induced hippocampal toxicity in rats by regulating Nrf2/HO-1, PPAR-γ, NF-κB/nNOS, and ROS/NLRP3/caspase-1 signaling pathways. J Biochem Mol Toxicol. 2023;37(9):e23414. doi:10.1002/jbt.23414
  7. Katturajan R, Vijayalakshmi S, Rasool M, Evan Prince S. Molecular toxicity of methotrexate in rheumatoid arthritis treatment: A novel perspective and therapeutic implications. Toxicology. 2021;461:152909. doi:10.1016/j.tox.2021.152909
  8. Arpag H, Gül M, Aydemir Y, et al. Protective effects of alpha-lipoic acid on methotrexate-induced oxidative lung injury in rats. J Invest Surg. 2018;31(2):107-113. doi:10.1080/08941939.2017.1296513
  9. Mohamed DI, Khairy E, Tawfek SS, Habib EK, Fetouh MA. Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat. Biomed Pharmacother. 2019;109:892-901. doi:10.1016/j.biopha.2018.10.133
  10. Bedoui Y, Guillot X, Sélambarom J, et al. Methotrexate an old drug with new tricks. Int J Mol Sci. 2019;20(20):5023. doi:10.3390/ijms20205023
APA
Demir, S., Türkmen Alemdar, N., Ayazoglu Demir, E., Mentese, A., & Aliyazıcıoğlu, Y. (2024). The Therapeutic Effect of p-Coumaric Acid on Lung Toxicity Induced by Methotrexate in Rats. Farabi Tıp Dergisi, 3(2), 57-62. https://doi.org/10.59518/farabimedj.1484155